Including interaction with homologous receptors in kidney cells, it exerts anti-inflammatory and oxidative stress effects to delay CKD progression by inhibiting the NF-κB and MAPK pathways [12,28]. This evidence concerns the gene NFKB1 and chronic kidney disease.